ERIC GOLD: Open Payments
NPI 1043326119 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,459 in 94 payments from 16 companies in 2025. Trend: 2023 $1,163 · 2024 $1,491 · 2025 $1,459
Food & beverage: $1,450Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $484 |
| Novartis Pharmaceuticals Corporation | 14 | $267 |
| Galderma Laboratories, L.P. | 17 | $262 |
| Janssen Biotech, Inc. | 8 | $135 |
| GENZYME CORPORATION | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| Incyte Corporation | 1 | $28 |
| LEO Pharma Inc. | 1 | $27 |
| UCB, Inc. | 1 | $25 |
Products named: SKYRIZI, NEMLUVIO, COSENTYX, TREMFYA, RINVOQ, DUPIXENT, Sotyktu, KOSELUGO.
Industry payments across NY — which companies pay providers there.
